ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 113 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $228,276 | -20.4% | 34,173 | 0.0% | 0.06% | -22.1% |
| Q2 2023 | $286,711 | -15.5% | 34,173 | 0.0% | 0.08% | -23.0% |
| Q1 2023 | $339,338 | +42.7% | 34,173 | 0.0% | 0.10% | +28.2% |
| Q4 2022 | $237,844 | +30.7% | 34,173 | 0.0% | 0.08% | +21.9% |
| Q3 2022 | $182,000 | +33.8% | 34,173 | 0.0% | 0.06% | +39.1% |
| Q2 2022 | $136,000 | -10.5% | 34,173 | 0.0% | 0.05% | -11.5% |
| Q1 2022 | $152,000 | -49.3% | 34,173 | 0.0% | 0.05% | -53.6% |
| Q3 2021 | $300,000 | -22.5% | 34,173 | 0.0% | 0.11% | -26.8% |
| Q2 2021 | $387,000 | -4.7% | 34,173 | 0.0% | 0.15% | -11.0% |
| Q1 2021 | $406,000 | +73.5% | 34,173 | 0.0% | 0.17% | +60.7% |
| Q4 2020 | $234,000 | -7.5% | 34,173 | 0.0% | 0.11% | -23.0% |
| Q3 2020 | $253,000 | +76.9% | 34,173 | 0.0% | 0.14% | +65.5% |
| Q2 2020 | $143,000 | +70.2% | 34,173 | 0.0% | 0.08% | +37.7% |
| Q1 2020 | $84,000 | – | 34,173 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,031,915 | $20,253,192 | 21.02% |
| Perceptive Advisors | 11,350,085 | $75,818,568 | 2.53% |
| JOHNSON & JOHNSON | 394,834 | $2,637,491 | 0.97% |
| Joseph P. Lucia & Associates, LLC | 28,331 | $189,251 | 0.13% |
| WOODSTOCK CORP | 137,179 | $916,356 | 0.12% |
| Palo Alto Investors LP | 160,800 | $1,074,144 | 0.10% |
| Affinity Asset Advisors, LLC | 44,348 | $296,245 | 0.08% |
| Verition Fund Management LLC | 935,273 | $6,247,624 | 0.07% |
| FOX RUN MANAGEMENT, L.L.C. | 33,519 | $223,907 | 0.07% |
| TOBIAS FINANCIAL ADVISORS, INC. | 34,173 | $228,276 | 0.06% |